“Development of Biodegradable and Bioresorbable Sealants”
The surgical sealants and adhesives market is witnessing a major trend in the development of biodegradable and bioresorbable sealants, driven by the growing demand for minimally invasive procedures and enhanced biocompatibility. These next-generation adhesives, designed to degrade naturally within the body, eliminate the need for post-surgical removal, reducing complications and improving patient outcomes. A key instance is Animus Surgical’s transparent, biodegradable hydrogel wound sealant, introduced in March 2023, which offers non-toxic wound closure with improved healing efficiency. Leading players such as Ethicon, Medtronic, and Baxter are investing in biodegradable polymers, fibrin-based adhesives, and synthetic hydrogels, aiming to provide strong adhesion, reduced inflammatory response, and enhanced tissue integration. The rise of bioengineered adhesives is transforming the market, particularly in cardiovascular, orthopedic, and CNS surgeries, where precision, durability, and resorption rate are critical. As regulatory approvals increase, biodegradable solutions are expected to dominate the future landscape of surgical wound management.
